Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter lock solutions for prevention of bloodstream infection in hemodialysis
RBR-6vfg7rCompleted
- Sponsor
- Universidade Estadual Paulista
- Start
- Nov 2014
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of gentamicin, cefazolin, heparin, taurolidine and trisodium citrate in catheter-associated bloodstream infection (CRBSI) (2 arms), sponsored by Universidade Estadual Paulista. Started Nov 2014; status: completed.
02
Drugs
gentamicincefazolinheparintaurolidinetrisodium citrate
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on RBR-6vfg7r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6vfg7r.